Biomedical application of fuzzy association rules for identifying breast cancer biomarkers

The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis

(2010) Song En-lin et al.   GYNECOLOGIC ONCOLOGY

Discovering protein–DNA binding sequence patterns using association rule mining

(2010) Kwong-Sak Leung et al.   NUCLEIC ACIDS RESEARCH

NCBI GEO: archive for functional genomics data sets--10 years on

(2010) T. Barrett et al.   NUCLEIC ACIDS RESEARCH

FISim: A new similarity measure between transcription factor binding sites based on the fuzzy integral

(2009) Fernando Garcia et al.   BMC BIOINFORMATICS

SCUBE2 Suppresses Breast Tumor Cell Proliferation and Confers a Favorable Prognosis in Invasive Breast Cancer

(2009) C.-J. Cheng et al.   CANCER RESEARCH

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

(2009) Donal J. Brennan et al.   EUROPEAN JOURNAL OF CANCER

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations

(2009) Guido Sauter et al.   JOURNAL OF CLINICAL ONCOLOGY

Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?

(2009) A H Sims   JOURNAL OF CLINICAL PATHOLOGY

EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma

(2009) H. Seeliger et al.   MOLECULAR CANCER RESEARCH

Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion

(2009) B. Hu et al.   MOLECULAR CANCER RESEARCH

Fuzzy association rules for biological data analysis: A case study on yeast

(2008) Francisco J Lopez et al.   BMC BIOINFORMATICS

Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis

(2008) Mads Thomassen et al.   BREAST CANCER RESEARCH AND TREATMENT

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease

(2008) M W Helms et al.   BRITISH JOURNAL OF CANCER

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

(2008) Ariane Sadr-Nabavi et al.   INTERNATIONAL JOURNAL OF CANCER

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing

(2008) Isabelle Vanden Bempt et al.   JOURNAL OF CLINICAL ONCOLOGY

The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties

(2008) Peter Dy et al.   NUCLEIC ACIDS RESEARCH

Systematic Review of HER2 Breast Cancer Testing

(2008) Marta Cuadros et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

(2007) S. Ek et al.   BLOOD